NSTS Bancorp, Inc.

NSTS

CIK 0001881592 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$63K
↓-1.6% -$1Kvs FY2024 (Q4)
Gross Profit
$63K
↓-1.6% -$1Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
2/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.00x (1.0+ = capital-efficient)
  • Growth
    11Revenue YoY -1.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project NSTS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

12%

Trailing 3-yr CAGR was 12.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$16.34
Total enterprise IV
$80M
Diluted shares
0.00B
Terminal PV
$59M (74% of total)
Year-5 FCF
$7M
YearProjected FCFDiscounted PV
+1$4M$4M
+2$5M$4M
+3$6M$4M
+4$6M$4M
+5$7M$4M
Terminal$95M$59M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$104K
investment in PP&E
Stock buybacks (TTM)
$0
share count reduction
Stock-based comp (TTM)
$678K
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$267M
everything owned
Total liabilities
$187M
everything owed
Stockholders' equity
$80M
shareholder claim

Recent performance · 22 quarters

Revenue↓-1.6% -$1K
$63K
Net Income↑+138.0% +$236K
$65K
Free Cash Flow↓-65.3% -$6M
$3M

Drill down